An automated method for measurement of methoxetamine in human plasma by use of turbulent flow on-line extraction coupled with liquid chromatography and mass spectrometric detection

Analytical and Bioanalytical Chemistry

Volumn 405, Issue 1, 2013, Pages 239-245

  Abe, Emuri ^a   Ricard, Florian ^a   Darrouzain, François ^b   Alvarez, Jean Claude ^a  

^a RAYMOND POINCARÉ HOSPITAL   (France)

^b UNIVERSITY HOSPITAL OF TOURS   (France)

Author keywords

Designer drugs; LC MS MS; Methoxetamine; On line extraction

Indexed keywords

ANALYTES; ANALYTICAL COLUMNS; AUTOMATED METHODS; CASE REPORTS; CHROMATOGRAPHIC SEPARATIONS; COEFFICIENTS OF VARIATIONS; DESIGNER DRUGS; ELECTROSPRAYS; HUMAN PLASMAS; INTERNAL STANDARDS; ION TRAPS; KETAMINE; LC-MS-MS; LOWER LIMIT OF QUANTIFICATIONS; MASS SPECTROMETRIC DETECTION; MATRIX EFFECTS; METHOXETAMINE; NMDA RECEPTOR; ONLINE EXTRACTION; PLASMA CONCENTRATION; POSITIVE MODE; RECREATIONAL DRUGS; SAMPLE PREPARATION; UPPER LIMITS;

ACETONITRILE; AMINES; CENTRIFUGATION; IONS; MASS SPECTROMETERS; PLASMA (HUMAN);

LIQUID CHROMATOGRAPHY;

2 (3 METHOXYPHENYL) 2 (ETHYLAMINO)CYCLOHEXANONE; 2-(3-METHOXYPHENYL)-2-(ETHYLAMINO)CYCLOHEXANONE; ACETONITRILE; ACETONITRILE DERIVATIVE; BUFFER; CYCLOHEXANONE DERIVATIVE; CYCLOHEXYLAMINE DERIVATIVE; ION; KETAMINE;

ADULT; ARTICLE; AUTOMATION; CALIBRATION; CHEMISTRY; CHROMATOGRAPHY; FRANCE; HOSPITALIZATION; HUMAN; LIQUID CHROMATOGRAPHY; METABOLISM; METHODOLOGY; PLASMA; QUALITY CONTROL; REPRODUCIBILITY; TANDEM MASS SPECTROMETRY; TIME;

ACETONITRILES; ADULT; AUTOMATION; BUFFERS; CALIBRATION; CHROMATOGRAPHY; CHROMATOGRAPHY, LIQUID; CYCLOHEXANONES; CYCLOHEXYLAMINES; FRANCE; HOSPITALIZATION; HUMANS; IONS; KETAMINE; PLASMA; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY; TIME FACTORS;

EID: 84872347239     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-012-6470-0     Document Type: Article

References (14)

1. Corazza O, Schifano F, Simonato P, Fergus S, Assi S, Stair J, Corkery J, Trincas G, Deluca P, Davey Z, Blaszko U, Demetrovics Z, Moskalewicz J, Enea A, di Melchiorre G, Mervo B, di Furia L, Farre M, Flesland L, Pasinetti M, Pezzolesi C, Pisarska A, Shapiro H, Siemann H, Skutle A, Sferrazza E, Torrens M, van der Kreeft P, Zummo D, Scherbaum N (2012) Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine. Hum Psychopharmacol 27(2):145-149
2. Hofer KE, Grager B, Muller DM, Rauber-Luthy C, Kupferschmidt H, Rentsch KM, Ceschi A (2012) Ketamine-like effects after recreational use of methoxetamine. Ann Emerg Med 60(1):97-99
3. Wood DM, Hunter L, Measham F, Dargan PI (2012) Limited use of novel psychoactive substances in South London nightclubs. QJM, Jun 19. [Epub ahead of print]
4. Schmidt MM, Sharma A, Schifano F, Feinmann C (2011) Legal highs on the net-Evaluation of UK-based Websites, products and product information. Forensic Sci Int 206(1-3):92-97
5. Westwell AD, Hutchings A, Caldicott DG (2012) The identification and chemical characterization of a new arylcyclohexylamine, methoxetamine, using a novel Emergency Department toxicosurveillance tool. Drug Test Anal [Epub ahead of print]
6. Rosenbaum CD, Carreiro SP, Babu KM (2012) Here today, gone tomorrow.and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines. J Med Toxicol 8(1):15-32
7. Ward J, Rhyee S, Plansky J, Boyer E (2011) Methoxetamine: a novel ketamine analog and growing health-care concern. Clin Toxicol (Phila) 49(9):874-875
8. Wood DM, Davies S, Puchnarewicz M, Johnston A, Dargan PI (2012) Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine. Eur J Clin Pharmacol 68(5):853-856
9. Shields JE, Dargan PI, Wood DM, Puchnarewicz M, Davies S, Waring WS (2012) Methoxetamine associated reversible cerebellar toxicity: three cases with analytical confirmation. Clin Toxicol (Phila) 50(5):438-440
10. Wood DM, Dargan PI (2012) Novel Psychoactive Substances: How to Understand the Acute Toxicity Associated With the Use of These Substances. Ther Drug Monit
11. Gibbons S (2012) 'Legal highs' - novel and emerging psychoactive drugs: a chemical overview for the toxicologist. Clin Toxicol (Phila) 50(1):15-24
12. Couchman L (2012) Turbulent flow chromatography in bioanalysis: a review. Biomed Chromatogr 26(8):892-905
13. Couchman L, Birch M, Ireland R, Corrigan A, Wickramasinghe S, Josephs D, Spicer J, Flanagan RJ (2012) An automated method for the measurement of a range of tyrosine kinase inhibitors in human plasma or serum using turbulent flow liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 403(6):1685-1695
14. Couchman L, Buckner SL, Morgan PE, Ceesay MM, Pagliuca A, Flanagan RJ (2012) An automated method for the simultaneous measurement of azole antifungal drugs in human plasma or serum using turbulent flow liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 404(2):513-523